Method of Targeting a Therapeutic Agent to Cells Expressing the erbB-3 Receptor
Technology
E-221-1989
Patent ID
E-221-1989-1-US-02
Country
US
Application Type
DIV
Patent Status
Expired
Patent Number
5820859
Publication Number
Application Number
08/473,119
IC
NCI
Date Filed
Date Issued